These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31318438)

  • 1. Immuno-oncology for surgeons.
    Lee SL; Al-Shamkhani A; Mirnezami A
    Br J Surg; 2019 Sep; 106(10):1273-1282. PubMed ID: 31318438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-oncology-101: overview of major concepts and translational perspectives.
    Allard B; Aspeslagh S; Garaud S; Dupont FA; Solinas C; Kok M; Routy B; Sotiriou C; Stagg J; Buisseret L
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):1-11. PubMed ID: 29428479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
    Cui X; Wang Q; Kang C
    Front Immunol; 2021; 12():788733. PubMed ID: 34777399
    [No Abstract]   [Full Text] [Related]  

  • 4. The hubris and humility of cancer pharmacology in the post immuno-oncology era.
    Lazo JS
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00527. PubMed ID: 31624635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized Immuno-Oncology.
    Jain KK
    Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second- and third-generation drugs for immuno-oncology treatment-The more the better?
    Dempke WCM; Fenchel K; Uciechowski P; Dale SP
    Eur J Cancer; 2017 Mar; 74():55-72. PubMed ID: 28335888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-Oncology in China.
    Lu S; Chabner BA
    Oncologist; 2019 Feb; 24(Suppl 1):S1-S2. PubMed ID: 30819825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell engagers in cancer immunotherapy: Next generation of immuno-oncology treatments.
    Demaria O; Gauthier L; Debroas G; Vivier E
    Eur J Immunol; 2021 Aug; 51(8):1934-1942. PubMed ID: 34145579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of DC-SIGN
    Hu B; Wang Z; Zeng H; Qi Y; Chen Y; Wang T; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
    Cancer Res; 2020 Apr; 80(8):1707-1719. PubMed ID: 32060149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New treatments in immuno-oncology: a revolution and a formidable scientific and clinical challenge].
    Champiat S; Soria JC
    Med Sci (Paris); 2017; 33(6-7):563-564. PubMed ID: 28990546
    [No Abstract]   [Full Text] [Related]  

  • 11. Humanized Mice for the Study of Immuno-Oncology.
    De La Rochere P; Guil-Luna S; Decaudin D; Azar G; Sidhu SS; Piaggio E
    Trends Immunol; 2018 Sep; 39(9):748-763. PubMed ID: 30077656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The revolution of immuno-oncology therapy: review of immune checkpoint inhibitors efficacy].
    Dubois M; Ardin C; André F; Scherpereel A; Mortier L
    Med Sci (Paris); 2019 Dec; 35(12):937-945. PubMed ID: 31903897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [At the crossroads of cancer].
    Chouaib S
    Bull Cancer; 2013 Jun; 100(6):569-74. PubMed ID: 23735599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapeutic Transport Oncophysics: Space, Time, and Immune Activation in Cancer.
    Nizzero S; Shen H; Ferrari M; Corradetti B
    Trends Cancer; 2020 Jan; 6(1):40-48. PubMed ID: 31952780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy.
    Yu WD; Sun G; Li J; Xu J; Wang X
    Cancer Lett; 2019 Jun; 452():66-70. PubMed ID: 30902563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Nanomedicine: Lessons for Immuno-Oncology.
    Sengupta S
    Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
    Wang H; Franco F; Ho PC
    Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research evolutions in immuno-oncology and their impact on the management of patients treated with immunotherapy].
    Caux C
    Bull Cancer; 2020 Jan; 107(1):6-9. PubMed ID: 31954504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.
    Zeng D; Ye Z; Shen R; Yu G; Wu J; Xiong Y; Zhou R; Qiu W; Huang N; Sun L; Li X; Bin J; Liao Y; Shi M; Liao W
    Front Immunol; 2021; 12():687975. PubMed ID: 34276676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations.
    Wong RL; Yu EY
    Curr Treat Options Oncol; 2021 Jan; 22(2):13. PubMed ID: 33433743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.